These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19205505

  • 1. Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab.
    Kovach JL, Schwartz SG, Hickey M, Puliafito CA.
    Ophthalmic Surg Lasers Imaging; 2009; 40(1):77-9. PubMed ID: 19205505
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.
    Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C.
    Arch Ophthalmol; 2007 Oct; 125(10):1422-3. PubMed ID: 17923555
    [No Abstract] [Full Text] [Related]

  • 3. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
    Teixeira A, Moraes N, Farah ME, Bonomo PP.
    Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
    Sachdev N, Vishwanathan K, Gupta V, Singh R, Gupta A.
    Indian J Ophthalmol; 2007 Dec; 55(6):457-8. PubMed ID: 17951904
    [Abstract] [Full Text] [Related]

  • 8. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
    Teixeira A, Mattos T, Velletri R, Teixeira R, Freire J, Moares N, Bonomo PP.
    Ophthalmic Surg Lasers Imaging; 2010 Dec; 41(5):546-9. PubMed ID: 20795575
    [Abstract] [Full Text] [Related]

  • 9. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
    Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y.
    Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study.
    Rosina C, Romano M, Cigada M, de Polo L, Staurenghi G, Bottoni F.
    Eur J Ophthalmol; 2015 Oct; 25(1):47-50. PubMed ID: 25044143
    [Abstract] [Full Text] [Related]

  • 11. Rapid progression of angioid streaks following intravitreal bevacizumab.
    Sen PR, Rishi P, Sen P, Rishi E, Shroff D.
    Can J Ophthalmol; 2009 Oct; 44(5):e39-40. PubMed ID: 19798813
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drastic effect of ranibizumab on choroidal neovascularization in idiopathic angioid streaks.
    Yolcu U, Gundogan FC, Diner O.
    Arq Bras Oftalmol; 2015 Oct; 78(4):257-9. PubMed ID: 26375345
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.
    Battaglia Parodi M, Iacono P, La Spina C, Berchicci L, Scotti F, Leys A, Introini U, Bandello F.
    Am J Ophthalmol; 2014 Feb; 157(2):374-377.e2. PubMed ID: 24211865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.